MLN Matters Articles
MLN Matters® Articles
These Articles explain national Medicare policies on coverage, billing, and payment rules for specific provider types. Sometimes we explain information in an MLN Connects® newsletter message instead of an MLN Matters® Article. If there’s an Article or a newsletter message, you’ll find it in the “Provider Education” column.
The COVID-19 public health emergency (PHE) ended on May 11, 2023. View Infectious diseases for a list of waivers and flexibilities that were in place during the PHE.
You can filter by subject or Article number. To search all years, leave the Transmittal Year as "Any."
Displaying 831 - 840 of 8867
| Transmittal # | Issue Date Sort ascending | Subject | Implementation Date | CR # | Provider Education | Provider Education Release Date | Provider Education Revision Date |
|---|---|---|---|---|---|---|---|
| R11769BP | Manual Update Pub. 100-02 Medicare Benefit Policy, Chapter 15, Section 110.8 Durable Medical… |
13028 | MLN Connects Newsletter Message | ||||
| R11771PI | Internet-Only Manual (IOM) Updates for Nurse Practitioners (NPs) and Clinical Nurse Specialists… |
13029 | |||||
| R11774CP | National Coverage Determination (NCD 110.24): Chimeric Antigen Receptor (CAR) Tcell Therapy |
12928 | MLN Matters Article MM12928 | ||||
| R11768CP | Remittance Advice Remark Code (RARC), Claims Adjustment Reason Code (CARC), Medicare Remit Easy… |
13007 | MLN Connects Newsletter Message | ||||
| R11772OTN | Changes to Beneficiary Coinsurance for Additional Procedures Furnished During the Same Clinical… |
12656 | MLN Matters Article MM12656 | ||||
| R18P240i | Part 2, Provider Cost Reporting Forms and Instructions, Chapter 40, Form CMS-2552-10 |
||||||
| R11767BP | Implementation of Changes in the End-Stage Renal Disease (ESRD) Prospective Payment |
12978 | MLN Matters Article MM12978 | ||||
| R11764BP | New Medicare Part B Immunosuppressant Drug Benefit (PBID) - Implementation |
12804 | MLN Matters Article MM12804 | ||||
| R11764GI | New Medicare Part B Immunosuppressant Drug Benefit (PBID) - Implementation |
12804 | MLN Matters Article MM12804 | ||||
| R11764CP | New Medicare Part B Immunosuppressant Drug Benefit (PBID) - Implementation |
12804 | MLN Matters Article MM12804 |
Page Last Modified:
11/19/2024 06:23 PM